Hepatitis C virus

Results: 919



#Item
101

PDF Document

Add to Reading List

Source URL: hepqld.asn.au

Language: English - Date: 2013-04-15 23:28:50
102

PDF Document

Add to Reading List

Source URL: hepqld.asn.au

Language: English - Date: 2013-04-15 23:30:52
103Übertragung und Inaktivierung des Hepatitis C Virus PD Dr. Eike Steinmann Centre for Experimental and Clinical Infection Research Institute of Experimental Virology, Twincore* *joint venture between Medical School Hann

Übertragung und Inaktivierung des Hepatitis C Virus PD Dr. Eike Steinmann Centre for Experimental and Clinical Infection Research Institute of Experimental Virology, Twincore* *joint venture between Medical School Hann

Add to Reading List

Source URL: www.akzept.org

Language: English - Date: 2014-11-16 07:59:28
104Drugs and HCV: a look at Romania Ionut Alexandrescu, Carusel Foundation (Romania) According to the World Health Organization’s data, Romania has the highest rate of Hepatitis C Virus (HCV) prevalence in Europe. Moreove

Drugs and HCV: a look at Romania Ionut Alexandrescu, Carusel Foundation (Romania) According to the World Health Organization’s data, Romania has the highest rate of Hepatitis C Virus (HCV) prevalence in Europe. Moreove

Add to Reading List

Source URL: www.correlation-net.org

Language: English - Date: 2014-12-06 09:29:52
105People who inject drugs: HIV and viral hepatitis monitoring among people who inject image and performance enhancing drugs

People who inject drugs: HIV and viral hepatitis monitoring among people who inject image and performance enhancing drugs

Add to Reading List

Source URL: webarchive.nationalarchives.gov.uk

Language: English
106A Single Subcutaneous Dose of 2 mg/kg or 4 mg/kg of RG-101, a GalNAc-Conjugated Oligonucleotide with Antagonist Activity against miR-122, Results in Significant Viral Load Reductions in Chronic Hepatitis C Patients

A Single Subcutaneous Dose of 2 mg/kg or 4 mg/kg of RG-101, a GalNAc-Conjugated Oligonucleotide with Antagonist Activity against miR-122, Results in Significant Viral Load Reductions in Chronic Hepatitis C Patients

Add to Reading List

Source URL: files.shareholder.com

Language: English
107RG-101, A NOVEL GALNAC-CONJUGATED INHIBITOR OF MICRORNA-122, DEMONSTRATES SIGNIFICANT VIRAL LOAD REDUCTION AND REDUCES LIVER STEATOSIS IN HUMAN HEPATOCYTE CHIMERIC MICE INFECTED WITH GENOTYPE 1A OR HARD-TO-TREAT GENOTYPE

RG-101, A NOVEL GALNAC-CONJUGATED INHIBITOR OF MICRORNA-122, DEMONSTRATES SIGNIFICANT VIRAL LOAD REDUCTION AND REDUCES LIVER STEATOSIS IN HUMAN HEPATOCYTE CHIMERIC MICE INFECTED WITH GENOTYPE 1A OR HARD-TO-TREAT GENOTYPE

Add to Reading List

Source URL: files.shareholder.com

Language: English
108Morbidity and Mortality Weekly Report Notes from the Field Deaths from Acute Hepatitis B Virus Infection Associated with Assisted Blood Glucose Monitoring in an Assisted-Living Facility —

Morbidity and Mortality Weekly Report Notes from the Field Deaths from Acute Hepatitis B Virus Infection Associated with Assisted Blood Glucose Monitoring in an Assisted-Living Facility —

Add to Reading List

Source URL: www.2ndchance.info

Language: English - Date: 2014-02-04 17:16:04
109Minimal-length Synthetic shRNAs Formulated with Lipid Nanoparticles are Potent Inhibitors of Hepatitis C Virus IRES-linked Gene Expression in Mice

Minimal-length Synthetic shRNAs Formulated with Lipid Nanoparticles are Potent Inhibitors of Hepatitis C Virus IRES-linked Gene Expression in Mice

Add to Reading List

Source URL: www.tekmira.com

Language: English - Date: 2015-03-05 19:44:25
110Ministerial Advisory Committee on AIDS, Sexual Health and Hepatitis Hepatitis C Sub-Committee Hepatitis C Virus Projections Working Group:

Ministerial Advisory Committee on AIDS, Sexual Health and Hepatitis Hepatitis C Sub-Committee Hepatitis C Virus Projections Working Group:

Add to Reading List

Source URL: www.hepqld.asn.au

Language: English - Date: 2013-04-15 23:27:41